Literature DB >> 7211178

Risk factors in multiple sclerosis: tuberculin reactivity, age at measles infection, tonsillectomy and appendectomy.

E Andersen, H Isager, K Hyllested.   

Abstract

The purpose of the present study was to investigate whether risk of multiple sclerosis (MS) is associated with the occurrence of viral or bacterial diseases, with vaccinations, or with operative events during childhood. Our reference population was 198,000 persons recorded in the register of school health records from the Copenhagen council. We compared 92 MS patients contained in the register with matched controls from the register, three for each patients. Risk of MS was inversely associated with a positive tuberculin skin test at age 7 years, i.e. with exposure to tuberculosis before the age of 7, possibly also with the occurrence of measles infection before age 7 (not statistically significant). Disease risk was not significantly related to other viral or bacterial infections of childhood, nor to routine vaccinations, tonsillectomy, adenoidectomy or appendectomy. Our findings suggest a difference between MS patients and controls with respect to environment before school age, the former being less exposed to air-borne infections.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7211178     DOI: 10.1111/j.1600-0404.1981.tb00756.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  14 in total

1.  Age at childhood infections and risk of atopy.

Authors:  P Bager; T Westergaard; K Rostgaard; H Hjalgrim; M Melbye
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 2.  Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.

Authors:  Mauricio F Farez; Jorge Correale
Journal:  J Neurol       Date:  2011-03-24       Impact factor: 4.849

3.  Epidemiology of multiple sclerosis in the north-east (Grampian region) of Scotland--an update.

Authors:  J G Phadke; A W Downie
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

4.  Multicenter case-control study of multiple sclerosis and risk factors. Design of study. The Coordinating Center and the Neurological Centers of the Cooperative Group.

Authors: 
Journal:  Ital J Neurol Sci       Date:  1986-04

5.  Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.

Authors:  Diane L Sewell; Emily K Reinke; Dominic O Co; Laura H Hogan; Robert B Fritz; Matyas Sandor; Zsuzsa Fabry
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

6.  HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection.

Authors:  G Lamoureux; P Duquette; Y Lapierre; B Cosgrove; G Bourret; L Labrie
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

7.  Immunological treatment of multiple sclerosis.

Authors:  R A Hughes
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

8.  Past infectious events and disease evolution in multiple sclerosis.

Authors:  G Lamoureux; Y Lapierre; G Ducharme
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

Review 9.  Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.

Authors:  Carole Lunny; Jennifer A Knopp-Sihota; Shawn N Fraser
Journal:  BMC Neurol       Date:  2013-05-06       Impact factor: 2.474

10.  Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies.

Authors:  Sreeram V Ramagopalan; Raph Goldacre; Andrew Skingsley; Chris Conlon; Michael J Goldacre
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.